{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:04:40Z","timestamp":1783512280816,"version":"3.55.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"name":"VA Medical Centers"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-CA009314"],"award-info":[{"award-number":["T32-CA009314"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Establishing whether women with major depressive disorder who develop breast cancer have poor outcomes is key to optimizing care for this population. To this end, we examined associations between major depressive disorder and breast cancer recurrence and mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using medical record data from the US Department of Veterans Affairs health-care system, we established a retrospective cohort of women with local or regional stage invasive breast cancer between 2010 and 2019 and followed them through 2022. We used a 2-year window to identify women diagnosed with major depressive disorder before breast cancer diagnosis. We used multivariable Cox-proportional hazards regression to estimate associations between major depressive disorder and breast cancer recurrence and mortality while accounting for competing risks and adjusting for sociodemographic, clinical, lifestyle, and tumor characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 6051 women with breast cancer, of whom 1754 (29%) had major depressive disorder. The mean (SD) age at breast cancer diagnosis was 57 (11)\u2009years. In multivariable analyses, women with major depressive disorder had a 37% (hazard ratio\u2009=\u20091.37, 95% CI\u2009=\u20091.19 to 1.57) higher risk of recurrence and a 30% (hazard ratio\u2009=\u20091.30, 95% CI\u2009=\u20091.02 to 1.64) higher risk of breast cancer mortality. The association between major depressive disorder and recurrence was stronger among women with estrogen receptor\u2013positive breast cancer. In secondary analyses, there were statistically significant interactions between major depressive disorder and multiple exposures with respect to recurrence, including current smoking, substance abuse, and nonreceipt of screening mammography.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Women with major depressive disorder had inferior breast cancer outcomes compared with women without a history of major depressive disorder. Research is needed to investigate underlying mechanisms linking depression to breast cancer progression and evaluate interventions to improve outcomes in this high-risk population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djae287","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:52:47Z","timestamp":1731430367000},"page":"653-664","source":"Crossref","is-referenced-by-count":6,"title":["Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study"],"prefix":"10.1093","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-4250","authenticated-orcid":false,"given":"Maya","family":"Aboumrad","sequence":"first","affiliation":[{"name":"White River Junction VA Medical Center , White River Junction, VT 05009,","place":["United States"]},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD 21205,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-172X","authenticated-orcid":false,"given":"Corinne","family":"Joshu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD 21205,","place":["United States"]},{"name":"Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , Baltimore, MD 21205,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0582-8005","authenticated-orcid":false,"given":"Kala","family":"Visvanathan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD 21205,","place":["United States"]},{"name":"Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , Baltimore, MD 21205,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"2025040623575809700_djae287-B1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-019-05271-3","article-title":"Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis","volume":"176","author":"Pilevarzadeh","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"2025040623575809700_djae287-B2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PSY.0000000000000942","article-title":"Major depression and survival in people with cancer","volume":"83","author":"Walker","year":"2021","journal-title":"Psychosom Med"},{"key":"2025040623575809700_djae287-B3","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/s41380-020-00865-6","article-title":"Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients","volume":"25","author":"Wang","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2025040623575809700_djae287-B4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: a meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychol Med"},{"key":"2025040623575809700_djae287-B5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jnci\/djt211","article-title":"Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival","volume":"105","author":"Chubak","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2025040623575809700_djae287-B6","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis","volume":"115","author":"Satin","year":"2009","journal-title":"Cancer"},{"key":"2025040623575809700_djae287-B7","doi-asserted-by":"crossref","first-page":"18334","DOI":"10.1038\/s41598-019-54677-y","article-title":"Association of pre-existing depression with all-cause, cancer-related, and noncancer-related mortality among 5-year cancer survivors: a population-based cohort study","volume":"9","author":"Ko","year":"2019","journal-title":"Sci Rep"},{"key":"2025040623575809700_djae287-B8","doi-asserted-by":"crossref","first-page":"e221875","DOI":"10.1001\/jamanetworkopen.2022.1875","article-title":"Electronic Population-Based Depression Detection and Management Through Universal Screening in the Veterans Health Administration","volume":"5","author":"Leung","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025040623575809700_djae287-B9","author":"The Management of Major Depressive Disorder Work Group","year":"2009"},{"key":"2025040623575809700_djae287-B10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12913-018-3108-8","article-title":"Availability of healthcare providers for rural veterans eligible for purchased care under the veterans choice act","volume":"18","author":"Ohl","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2025040623575809700_djae287-B11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00127-019-01785-9","article-title":"Social connectedness, depression symptoms, and health service utilization: a longitudinal study of Veterans Health Administration patients","volume":"55","author":"Chen","year":"2020","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2025040623575809700_djae287-B12","doi-asserted-by":"crossref","first-page":"e1883","DOI":"10.7205\/MILMED-D-16-00371","article-title":"Cancer incidence among patients of the US Veterans Affairs Health Care System: 2010 update","volume":"182","author":"Zullig","year":"2017","journal-title":"Mil Med"},{"key":"2025040623575809700_djae287-B13","volume-title":"Joint Department of Veterans Affairs (VA) and Department of Defense (DoD) Suicide Data Repository","author":"Center of Excellence for Suicide Prevention","year":"2017"},{"key":"2025040623575809700_djae287-B14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"key":"2025040623575809700_djae287-B15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2025040623575809700_djae287-B16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12888-018-1990-6","article-title":"Validation of a case definition for depression in administrative data against primary chart data as a reference standard","volume":"19","author":"Doktorchik","year":"2019","journal-title":"BMC Psychiatry"},{"key":"2025040623575809700_djae287-B17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10654-022-00921-1","article-title":"Circulating vitamin D and breast cancer risk: An international pooling project of 17 cohorts","volume":"38","author":"Visvanathan","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"2025040623575809700_djae287-B18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity: a critical review of available methods","volume":"56","author":"De Groot","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"2025040623575809700_djae287-B19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1748-0361.2009.00200.x","article-title":"Do older rural and urban veterans experience different rates of unplanned readmission to VA and non-VA hospitals?","volume":"25","author":"Weeks","year":"2009","journal-title":"J Rural Health"},{"key":"2025040623575809700_djae287-B20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7205\/MILMED-D-15-00094","article-title":"Veterans Affairs health system enrollment and health care utilization after the Affordable Care Act: initial insights","volume":"181","author":"Silva","year":"2016","journal-title":"Mil Med"},{"key":"2025040623575809700_djae287-B21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/20009666.2016.1264696","article-title":"Prevalence and risk factors of heart failure in the USA: NHANES 2013\u20132014 epidemiological follow-up study","volume":"7","author":"Komanduri","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2025040623575809700_djae287-B22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/0003-4819-157-12-201212180-00003","article-title":"Associations between reduced hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 Veterans Affairs hospitals","volume":"157","author":"Kaboli","year":"2012","journal-title":"Ann Intern Med"},{"key":"2025040623575809700_djae287-B23","doi-asserted-by":"crossref","first-page":"e2024345","DOI":"10.1001\/jamanetworkopen.2020.24345","article-title":"Evaluation of changes in Veterans affairs medical centers\u2019 mortality rates after risk adjustment for socioeconomic status","volume":"3","author":"Trivedi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025040623575809700_djae287-B24","author":"Centers for Disease Control and Prevention, National Center for Health Statistics","year":"2019"},{"key":"2025040623575809700_djae287-B25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/aje\/kwp026","article-title":"Multiple imputation with large data sets: a case study of the Children's Mental Health Initiative","volume":"169","author":"Stuart","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2025040623575809700_djae287-B26","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2025040623575809700_djae287-B27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","journal-title":"Lancet"},{"key":"2025040623575809700_djae287-B28","doi-asserted-by":"crossref","first-page":"i5014","DOI":"10.1136\/bmj.i5014","article-title":"Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: Multi-database cohort study","volume":"354","author":"Donneyong","year":"2016","journal-title":"BMJ"},{"key":"2025040623575809700_djae287-B29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2011","journal-title":"Lancet"},{"key":"2025040623575809700_djae287-B30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","article-title":"Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: A patient-level meta-analysis of 7030 women from four randomised trials","volume":"23","author":"Bradley","year":"2022","journal-title":"Lancet Oncol"},{"key":"2025040623575809700_djae287-B31","doi-asserted-by":"crossref","first-page":"e794","DOI":"10.1200\/OP.20.00248","article-title":"Prescription patterns, initiation, and 5-year adherence to adjuvant hormonal therapy among commercially insured patients with breast cancer","volume":"17","author":"Zhao","year":"2021","journal-title":"J Clin Oncol Oncol Pract"},{"key":"2025040623575809700_djae287-B32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-016-3928-3","article-title":"Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study","volume":"159","author":"Valachis","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2025040623575809700_djae287-B33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10549-015-3471-7","article-title":"Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis","volume":"152","author":"Mausbach","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2025040623575809700_djae287-B34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-013-2422-4","article-title":"A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians","volume":"138","author":"Huiart","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2025040623575809700_djae287-B35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-018-5050-1","article-title":"Impact of preexisting mental illness on breast cancer endocrine therapy adherence","volume":"174","author":"Haskins","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"2025040623575809700_djae287-B36","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1007\/s00520-020-05585-9","article-title":"Adherence to adjuvant endocrine therapy among breast cancer survivors: A systematic review and meta-synthesis of the qualitative literature using grounded theory","volume":"28","author":"AlOmeir","year":"2020","journal-title":"Support Care Cancer"},{"key":"2025040623575809700_djae287-B37","first-page":"127","article-title":"Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer","volume":"9","author":"Kispert","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"2025040623575809700_djae287-B38","volume-title":"The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General","author":"Lushniak","year":"2014"},{"key":"2025040623575809700_djae287-B39","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1001\/jama.286.17.2143","article-title":"Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms","volume":"286","author":"Singletary","year":"2001","journal-title":"JAMA"},{"key":"2025040623575809700_djae287-B40","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3892\/ol.2015.2944","article-title":"Depression in cancer patients: pathogenesis, implications and treatment","volume":"9","author":"Smith","year":"2015","journal-title":"Oncol Lett"},{"key":"2025040623575809700_djae287-B41","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2147\/NDT.S213839","article-title":"The association between cortisol: C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol","volume":"15","author":"Sharpley","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2025040623575809700_djae287-B42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-0179-3-2","article-title":"Depression in cancer patients: a critical review","volume":"3","author":"Pasquini","year":"2007","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"2025040623575809700_djae287-B43","doi-asserted-by":"crossref","first-page":"e0252925","DOI":"10.1371\/journal.pone.0252925","article-title":"Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: a systematic review","volume":"16","author":"Salas","year":"2021","journal-title":"PLoS One"},{"key":"2025040623575809700_djae287-B44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.breast.2021.02.009","article-title":"Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis","volume":"57","author":"Salvo","year":"2021","journal-title":"Breast"},{"key":"2025040623575809700_djae287-B45","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/jnci\/djn233","article-title":"Residual risk of breast cancer recurrence 5 years after adjuvant therapy","volume":"100","author":"Brewster","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"2025040623575809700_djae287-B46","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","article-title":"Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy","volume":"29","author":"Arvold","year":"2011","journal-title":"J Clin Oncol"},{"key":"2025040623575809700_djae287-B47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.metabol.2005.01.014","article-title":"Depression in women","volume":"54","author":"Noble","year":"2005","journal-title":"Metabolism"},{"key":"2025040623575809700_djae287-B48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djae287\/60629427\/djae287.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/117\/4\/653\/60629427\/djae287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/117\/4\/653\/60629427\/djae287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:58:41Z","timestamp":1743983921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/117\/4\/653\/7896169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djae287","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,11,12]]}}}